Integrated Advisors Network
GSK icon

Integrated Advisors Network’s GSK GSK Stock Holding History

Integrated Advisors Network’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$301K Sell
6,240
-254
-4% -$13K 0.01% 560
2026
Q2 		$340K Sell
6,494
-733
-10% -$38.8K 0.02% 536
2026
Q1 		$399K Sell
7,227
-1,311
-15% -$71K 0.02% 499
2025
Q4 		$419K Sell
8,538
-1,205
-12% -$56.2K 0.02% 514
2025
Q3 		$420K Buy
9,743
+943
+11% +$36.8K 0.02% 546
2025
Q2 		$338K Sell
8,800
-914
-9% -$34.9K 0.02% 589
2025
Q1 		$376K Buy
9,714
+625
+7% +$22.9K 0.02% 528
2024
Q4 		$308K Sell
9,089
-2,876
-24% -$104K 0.01% 563
2024
Q3 		$489K Sell
11,965
-113
-0.9% -$4.62K 0.02% 477
2024
Q2 		$465K Buy
12,078
+381
+3% +$16K 0.02% 466
2024
Q1 		$502K Buy
11,697
+1,910
+20% +$78.8K 0.03% 465
2023
Q4 		$363K Buy
9,787
+1,265
+15% +$45.4K 0.02% 514
2023
Q3 		$309K Sell
8,522
-1
-0% -$35 0.02% 530
2023
Q2 		$304K Buy
8,523
+66
+0.8% +$2.37K 0.02% 536
2023
Q1 		$301K Buy
8,457
+2,170
+35% +$75.9K 0.02% 544
2022
Q4 		$221K Buy
+6,287
New +$209K 0.01% 572
2022
Q3 		– Sell
-86,666
Closed -$4.72M – 672
2022
Q2 		$4.72M Buy
86,666
+20,126
+30% +$1.11M 0.31% 89
2022
Q1 		$3.62M Buy
66,540
+61,542
+1,231% +$3.34M 0.21% 122
2021
Q4 		$276K Buy
4,998
+300
+6% +$15.6K 0.02% 545
2021
Q3 		$224K Buy
+4,698
New +$236K 0.01% 564
2020
Q4 		– Sell
-4,829
Closed -$227K – 508
2020
Q3 		$227K Sell
4,829
-2,250
-32% -$113K 0.03% 397
2020
Q2 		$361K Buy
7,079
+2,172
+44% +$111K 0.04% 308
2020
Q1 		$232K Sell
4,907
-37
-0.7% -$1.97K 0.05% 319
2019
Q4 		$290K Buy
+4,944
New +$275K 0.04% 331

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Integrated Advisors Network's GSK Position: Q3 2026 in Review

Integrated Advisors Network reduced its GSK (GSK) stake by 3.9% in Q3 2026, selling an estimated $13K and leaving 6,240 shares worth $301K. The position accounts for 0.01% of the portfolio, ranked #560.

Integrated Advisors Network first reported a position in GSK in Q4 2019 and has held it in 24 quarters since. The position peaked at $4.72M in Q2 2022. 654 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Integrated Advisors Network held 6,240 shares of GSK worth $301K as of Q3 2026.
  • Integrated Advisors Network sold 254 GSK shares in Q3 2026, an estimated $13K.
  • GSK made up 0.01% of Integrated Advisors Network's portfolio in Q3 2026, its #560 holding.
  • Integrated Advisors Network first reported a position in GSK in Q4 2019 and has held it in 24 quarters since.
  • Integrated Advisors Network's GSK position peaked at $4.72M in Q2 2022.
  • 654 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Integrated Advisors Network's 13F filing for Q3 2026, filed 20 Oct 2026.